Effects of zonisamide monotherapy on bone health in drug-naive epileptic patients.
Dae Lim KooHyunwoo NamPublished in: Epilepsia (2020)
The results suggest that long-term ZNS monotherapy does not affect bone health in drug-naive patients with epilepsy negatively.
Keyphrases
- healthcare
- public health
- end stage renal disease
- bone mineral density
- mental health
- ejection fraction
- chronic kidney disease
- newly diagnosed
- hiv infected
- combination therapy
- health information
- quantum dots
- open label
- prognostic factors
- emergency department
- bone loss
- postmenopausal women
- bone regeneration
- health promotion
- clinical trial
- randomized controlled trial
- social media
- adverse drug
- risk assessment
- human health
- double blind